Pharmaceutical

Formation Bio secures $372m funds for AI-driven drug platform

Formation Bio has secured $372m in Series D funding to bolster its drug pipeline and expand its AI-driven drug development platform.

Jun 28, 2024 - 04:00
Formation Bio secures $372m funds for AI-driven drug platform
Formation Bio has secured $372m in Series D funding to bolster its drug pipeline and expand its AI-driven drug development platform.
Read the original article

Tags:

Previous Article

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

Next Article

US CDC recommends routine RSV vaccination for older adults

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Embryo loss is integral to IVF. Alabama’s ruling equating embryos with children jeopardizes its practice

Embryo loss is integral to IVF. Alabama’s ruling equati...

Feb 23, 2024

Study finds same small rise in breast cancer risk in many forms of hormonal birth control

Study finds same small rise in breast cancer risk in ma...

Mar 22, 2023

Antengene and Hansoh partner to commercialise XPOVIO in China

Antengene and Hansoh partner to commercialise XPOVIO in...

Aug 12, 2023